Article
Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis?
Journal of translational medicine - 16 May 2014
Mansuet-Lupo Audrey, Zouiti Fouzia, Alifano Marco, Tallet Anne, Charpentier Marie-Christine, Ducruit Véronique, Devez Fabrice, Lemaitre Fanny, Laurent-Puig Pierre, Damotte Diane, Blons Hélène
Abstract excerpt
BACKGROUND: Activating epidermal growth factor receptor (EGFR) mutations characterize a subgroup of non-small-cell lung cancer that benefit from first line EGFR tyrosine kinase inhibitors (EGFR-TKI). However, the existence of polyclonal cell populations may hinder personalized-medicine strategies as patients' screening often depends upon a single tumor-biopsy sample. The purpose of this study is to clarify and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
